Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib-Reference-Cited by-同舟云学术

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib

Published:2009-01 Issue:1 Volume:33 Page:174-177
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Tiribelli Mario,Sperotto Alessandra,Candoni Anna,Simeone Erica,Buttignol Silvia,Fanin Renato

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia;Ottmann;Hematol Am Soc Hematol Educ Program,2005

2. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia;Kolb;Blood,1995

3. Donor leukocyte infusions in 140 patients with relapsed malignancies after allogeneic bone marrow transplantation;Collins;J Clin Oncol,1997

4. Donor leukocyte infusions in acute lymphocytic leukemia;Collins;Bone Marrow Transplant,2000

5. Donor leukocyte infusion for Japanese patients with relapsed luekemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome;Shiobara;Bone Marrow Transplant,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Remission Achieved by Modified Donor Lymphocyte Infusion Combined with Chemotherapy and Azacitidine Maintenance Therapy in a Patient with Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review;Advances in Clinical Medicine;2024

2. 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation;Clinical Cancer Research;2022-03-01

3. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2021-09

4. Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party;Bone Marrow Transplantation;2020-12-09

5. A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study;Leukemia;2020-11-17